I. Hickie et al., BIOCHEMICAL CORRELATES OF IN-VIVO CELL-MEDIATED IMMUNE DYSFUNCTION INPATIENTS WITH DEPRESSION - A PRELIMINARY-REPORT, International journal of immunopharmacology, 17(8), 1995, pp. 685-690
We have previously demonstrated that at least 50% of patients with mel
ancholia have impaired cell-mediated immunity (CMI) as assessed by del
ayed-type hypersensitivity (DTH) skin responses to a standardized batt
ery of antigens. Hypercortisolaemia and increased circulating catechol
amines both occur in patients with severe depressive disorders and eac
h has been proposed as a possible mediator of observed immune abnormal
ities in patients with mood disorders. As part of a lager study, we co
llected 24 h urine samples from 28 patients with major depression and
measured concentrations of urinary free cortisol (UFC), the noradrenal
ine metabolite dihydroxyphenylglycol (DHPG), adrenaline, and the dopam
ine metabolite DOPAC. CMI multitest skin testing revealed a reduced or
absent response in 54% of subjects. Those with reduced DTH skin respo
nses demonstrated increased urinary adrenaline (P<0.02), with trends t
owards increased UFC (P=0.052) and increased DHPG (P=0.06). These diff
erences could not be attributed to differences in age or depression se
verity. Correlational analyses demonstrated inverse associations betwe
en the extent of DTH responsiveness and 24 h levels of urinary adrenal
ine and DHPG, with similar trends evident for UFC and DOPAC. These res
ults suggest that both circulating catecholamines and cortisol may pla
y roles in the reduction of CMI in patients with severe depression.